Glucagon-like peptide 2 is an endogenous mediator of postresection intestinal adaptation

Journal of Parenteral and Enteral Nutrition

Volumn 29, Issue 2, 2005, Pages 97-101

  Perez, Alexander ^a   Duxbury, Mark ^a   Rocha, Flavio G ^a   Ramsanahie, Anthony P ^a   Farivar, Robert S ^a   Varnholt, Heike ^b   Ito, Hiromichi ^a   Wong, Helen ^c   Rounds, Jan ^a   Zinner, Michael J ^a   Whang, Edward E ^a   Ashley, Stanley W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 2; PROTEIN ANTIBODY; ANTIBODY; GLUCAGON LIKE PEPTIDE; PEPTIDE;

ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; INTESTINE ADAPTATION; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SMALL INTESTINE RESECTION; SURGICAL TECHNIQUE; ADAPTATION; ANIMAL; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; ILEUM; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY; RANDOMIZATION; SMALL INTESTINE; SPRAGUE DAWLEY RAT;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RATTUS;

ADAPTATION, PHYSIOLOGICAL; ANASTOMOSIS, SURGICAL; ANIMALS; ANTIBODIES; DISEASE MODELS, ANIMAL; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; ILEUM; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; PEPTIDES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 24044447315     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/014860710502900297     Document Type: Article

References (21)

1. Flint JM. The effect of extensive resection of the small intestine. Bull Johns Hopkins Hosp. 1912;23:127-144.
2. Senn N. An experimental contribution to intestinal surgery with special reference to the treatment of intestinal obstruction, II: enterectomy. Ann Surg. 1888;7:99-115.
3. Drucker DJ. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology. 2002;122:531-544.
4. Brubaker PL, Izzo A, Hill M, Drucker DJ. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol. 1997;272:E1050-E1058.
5. Drucker DJ, Erlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA. 1996;93:7911-7916.
6. Hartmann B, Thulesen J, Hare KJ, et al. Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats. Regul Pept. 2002;105:173-179.
7. Tavakkolizadeh A, Shen R, Abraham P, et al. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis. J Surg Res. 2000;91:77-82.
8. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
9. Hines OJ, Bilchik AJ, Zinner MJ, et al. Adaptation of the Na+/glucose cotransporter following intestinal resection. J Surg Res. 1994;57:22-27.
10. Tavakkolizadeh A, Whang EE. Understanding and augmenting human intestinal adaptation: a call for more clinical research. JPEN J Parenter Enteral Nutr. 2002;26:251-255.
11. Shanbhogue LK, Molenaar JC. Short bowel syndrome: metabolic and surgical management. Br J Surg. 1994;81:486-499.
12. Vanderhoof JA, Langnas AN. Short-bowel syndrome in children and adults. Gastroenterology. 1997;113:1767-1778.
13. Jeppesen PB, Hartmann B, Thulesen J, et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut. 2000;47:370-376.
14. Ulshen MH, Hoyt EC, Fuller CR, Ghatei MA, Bloom SR, Lund PK. Increased ileal proglucagon expression after jejunectomy is not suppressed by inhibition of bowel growth. Dig Dis Sci. 1996;41:677-683.
15. Martin GR, Wallace LE, Sigalet DL. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2004;286:G964-G972.
16. Ramsanahie A, Duxbury MS, Grikscheit TC, et al. Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine. Am J Physiol Gastrointest Liver Physiol. 2003;285:G1345-G1352.
17. Ramsanahie AP, Perez A, Duensing AU, Zinner MJ, Ashley SW, Whang EE. Glucagon-like peptide 2 enhances intestinal epithelial restitution. J Surg Res. 2002;107:44-49.
18. Jasleen J, Ashley SW, Shimoda N, Zinner MJ, Whang EE. Glucagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro. Dig Dis Sci. 2002;47:1135-1140.
19. Tavakkolizadeh A, Shen R, Abraham P, et al. Glucagonlike peptide 2 (glp-2) promotes intestinal recovery following chemotherapy-induced enteritis. Curr Surg. 2000;57:502.
20. Jasleen J, Shimoda N, Shen KR, et al. Signaling mechanisms of glucagon-like peptide 2-induced intestinal epithelial cell proliferation. J Surg Res. 2000;90:13-18.
21. Rocha FG, Shen KR, Jasleen J, et al. Glucagon-like peptide-2: divergent signaling pathways. J Surg Res. 2004;121:5-12.